NCT06020651 2026-04-08
VICKI
Institut Mutualiste Montsouris
Phase NA Completed
Clinical Trials
31 trialsNCT02822404 2026-04-01
CysPed
University Hospital, Toulouse
Phase NA Completed
NCT06435546 2026-03-27
AdOTAC
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT04662996 2026-02-12
MiR_CPMRC
University Hospital, Tours
Phase NA Completed
NCT07406646 2026-02-12
EXO-RENAL1
Institute of Oncology Ljubljana
Phase NA Completed
NCT02657863 2025-12-23
Cancer DNA Detection in Blood and Urine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT05141383 2025-09-08
HOPE
Institut Curie
Phase NA Completed
NCT05151341 2025-07-24
URODX-FGFR3
Institut de Cancérologie de Lorraine
Phase NA Completed
NCT01437488 2025-05-04
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
Thomas Jefferson University
Phase 2 Completed
NCT04883827 2024-10-22
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
Vanderbilt-Ingram Cancer Center
Completed
NCT05415787 2024-03-01
PROMECI
University Hospital, Tours
Completed
NCT03871816 2023-12-11
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Janssen Research & Development, LLC
Completed
NCT02070575 2023-10-23
Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence
Memorial Sloan Kettering Cancer Center
Completed
NCT04324983 2023-04-12
BioPoP
Martini-Klinik am UKE GmbH
Phase NA Completed
NCT04487457 2023-04-06
CINECI
University Hospital, Tours
Completed
NCT03247010 2022-11-09
Bone Marrow Suppression and Recovery During Radionuclide Treatment
Rigshospitalet, Denmark
Completed
NCT02329808 2022-05-10
PROTECT
Radboud University Medical Center
Completed
NCT04154163 2022-02-28
ADOPT
University of Dundee
Completed
NCT02376296 2022-02-17
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Saladax Biomedical, Inc.
Completed
NCT02235142 2022-01-20
AndroCan
Hopital Foch
Phase NA Completed
NCT02485964 2021-10-07
A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine
University of Arkansas
Phase NA Completed
NCT03816904 2021-04-28
NEUROTAX
University Hospital, Tours
Completed
NCT02246738 2020-12-10
Initial Evaluation of a Telomerase-based Circulating Tumor Cell Assay in Bladder Cancer Cohorts
Abramson Cancer Center at Penn Medicine
Completed
NCT03331367 2020-08-07
Investigating and Characterizing the Immune Response to Prostate Cancer
NYU Langone Health
Phase NA Completed
NCT02371551 2019-08-28
Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT
Insel Gruppe AG, University Hospital Bern
Completed
NCT03228810 2019-05-09
Genetic Biomarker Discovery for Metastatic Prostate Cancer
Mayo Clinic
Completed
NCT00798876 2019-05-07
Low-Fat Fish Oil Diet for Prostate Cancer Prevention
Jonsson Comprehensive Cancer Center
Phase NA Completed
NCT02297386 2018-08-06
[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01528774 2017-07-26
CTC
Comprehensive Cancer Centers of Nevada
Completed
NCT02424448 2016-07-26
BIOMETHS
The Christie NHS Foundation Trust
Completed
NCT02345473 2015-01-26
CirCanCell
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Completed